Ebola Vaccine: How Far are we?
Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 5
Abstract
Ebola viruses have been identified as an emerging threat as it causes severe haemorrhagic fever in human with mortality rates ranging from 50 to 90%. In addition to being a global health concern, the virus also is considered a potential biological threat agent. As for now, no licensed vaccine is available for pre or post exposure treatment. Recent epidemic of this disease in South Africa has led to concern towards development of an effective vaccine on a priority basis. This review is an attempt to look upon current progress in the development of Ebola virus vaccines and highlights strategies that have the greatest potential for commercial development.
Authors and Affiliations
Rajani Sharma, Ketki Jangid, Dr. Anuradha
Keywords
Related Articles
- EP ID EP341305
- DOI 10.7860/JCDR/2017/22184.9863
- Views 80
- Downloads 0
A Comparative Study of Supraclavicular Brachial Plexus Block with Clonidine as Adjuvant in Two Different Doses in Upper Limb Surgery
ABSTRACT Introduction: Supraclavicular route of brachial plexus block is considered as ‘The Spinal of Arm’, in which local anaesthetic agent is delivered at a point where the three trunks are compactly arranged and carry...
Qualitative Evaluation of ‘BIPP Dressing’ for Intraoral Mucosal Defect
ABSTRACT Introduction: Various biologic and non biologic graft materials are considered in the past as Intraoral wound dressing material. While autografts have issues related to donor site morbidity, allografts like coll...
Clinical and Laboratory Predictors of Frequency of Painful Crises among Sickle Cell Anaemia Patients in Nigeria
Introduction: The severity of Sickle Cell Anaemia (SCA) in terms of frequency of painful Vaso-Occlusive Crises (VOC) may be affected by clinical and haematological parameters amongst others. Elucidation of these factors...
Alexidine: a Safer and an Effective Root Canal Irrigant than Chlorhexidine
Introduction: Chlorhexidine (CHX) is generally used as the final irrigating solution in root canal therapy. Recent studies have reported that, toxic precipitates containing parachloroaniline (PCA) are formed when CHX rea...
Vitamin D in Treatment-Resistant Carpal Tunnel Syndrome Patients with Hypovitaminosis D
Introduction: Vitamin D significantly effects health. Extraskeletal effects of vitamin D play an important role. Aim: To study effect of treatment with vitamin D in intractable Carpal Tunnel Syndrome (CTS) patients with...